Showing results (161-170 of 361) with videos related to

Sort By:
Pageof 37
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumOriol Perera-Cruz, Lídia Mulet-Pons, Victor Montal, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthCarmen M Colceriu, Pablo Aguilar, Alex López, et al.
The Lancet. Neurology|September 3, 2018
Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional studyJuan Fortea, María Carmona-Iragui, Bessy Benejam, et al.
Molecular Neurodegeneration|August 19, 2020
Cerebrospinal fluid profile of NPTX2 supports role of Alzheimer's disease-related inhibitory circuit dysfunction in adults with Down syndromeOlivia Belbin, Mei-Fang Xiao, Desheng Xu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Dementia Care Research and Psychosocial FactorsLídia Vaqué-Alcázar, Laura Del Hoyo, Laura Videla, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 7, 2013
Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutationMarc Suárez-Calvet, Oriol Dols-Icardo, Albert Lladó, et al.
Journal of Intellectual Disability Research : JIDR|May 15, 2026
The Combined Role of Cognitive, Plasma, Volumetric and EEG Markers Along the Alzheimer's Disease Continuum in Down SyndromeJavier García-Alba, Elisa M Molanes-López, Pilar Zuluaga, et al.
Neurology|June 9, 2017
CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degenerationDaniel Alcolea, Eduard Vilaplana, Marc Suárez-Calvet, et al.
Scientific Reports|August 20, 2021
Regional grey matter microstructural changes and volume loss according to disease duration in multiple sclerosis patientsElisabeth Solana, Eloy Martinez-Heras, Victor Montal, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 11, 2025
Body mass index and blood volume influence plasma biomarkers and positron emission tomography classification in preclinical Alzheimer's diseaseTovia Jacobs, Courtney O' Brien, Luisa Figueredo, et al.
Pageof 37